(Q34136498)

31 July 2017

1 reference

title

Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape (English)

1 reference

evasion of host immune response

31 July 2017

1 reference

1 reference

2

Wick W

1 reference

31 July 2017

Platten M

1

1 reference

PubMed ID

11170299

31 July 2017

Weller M

series ordinal

3

1 reference

31 July 2017

1 February 2001

1 reference

Microscopy Research and Technique

31 July 2017

1 reference

31 July 2017

52

1 reference

31 July 2017

401-410

1 reference

31 July 2017

4

1 reference

A selective impairment of the IL-2 system in lymphocytes of patients with glioblastomas: increased level of soluble IL-2R and reduced protein tyrosine phosphorylation.

31 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Pharmacological properties of N-(3',4'-dimethoxycinnamoyl) anthranilic acid (N-5'), a new anti-atopic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Role of transforming growth factor beta in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Suppression of lymphokine-activated killer (LAK) cell induction mediated by interleukin-4 and transforming growth factor-beta 1: effect of addition of exogenous tumour necrosis factor-alpha and interferon-gamma, and measurement of their endogenous p

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Impairment of rosette-forming T lymphocytes in patients with primary intracranial tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Expression of HLA-DR and common acute lymphoblastic leukemia antigens on glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Thrombospondin-1 is a major activator of TGF-beta1 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Selective Sp1 and Sp3 binding is crucial for activity of the integrin alphaV promoter in cultured endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Immune defects observed in patients with primary malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Processing of transforming growth factor beta 1 precursor by human furin convertase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Activation of immunoregulatory lymphocytes obtained from patients with malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Inhibition of cytokine production by cyclosporin A and transforming growth factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Outcome and patterns of failure following limited-volume irradiation for malignant astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Malignant glioma: patterns of failure following individually tailored limited volume irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Human glioma-derived interleukin-10 inhibits antitumor immune responses in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Assumptions in the radiotherapy of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Distribution of transforming growth factor-beta 1 in human astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Activation of human platelet-derived latent transforming growth factor-β1 by human glioblastoma cells. Comparison with proteolytic and glycosidic enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Transforming growth factor-betas inhibit mitogen-stimulated proliferation of astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Resistance to growth inhibition by transforming growth factor-beta in malignant glioma cells with functional receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

The effect of transforming growth factor-beta 2-specific phosphorothioate-anti-sense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

TGF beta 1 and TGF beta 2 are potential growth regulators for low-grade and malignant gliomas in vitro: evidence in support of an autocrine hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

TGF beta 1 and TGF beta 2 are potential growth regulators for medulloblastomas, primitive neuroectodermal tumors, and ependymomas: evidence in support of an autocrine hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Vascular endothelial growth factor production is stimulated by gangliosides and TGF-beta isoforms in human glioma cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Inhibition of lymphocyte function by glioblastoma-derived transforming growth factor beta 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: a proposed model for indirect mitogenesis involving autocrine activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Sp1, but not Sp3, functions to mediate promoter activation by TGF-beta through canonical Sp1 binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Transforming growth factor-beta (TGF-beta)-mediated immunosuppression in the tumor-bearing state: enhanced production of TGF-beta and a progressive increase in TGF-beta susceptibility of anti-tumor CD4+ T cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Transforming growth factor-beta 1 in the rat brain: increase after injury and inhibition of astrocyte proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

The transcription factor EGR-1 directly transactivates the fibronectin gene and enhances attachment of human glioblastoma cell line U251.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

TGF-beta signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

The transforming growth factor-beta family

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Transcriptional control by the TGF-beta/Smad signaling system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Patterns of second recurrence of malignant astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Structural characterization of the latent complex between transforming growth factor beta 1 and beta 1-latency-associated peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor beta 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Radiation therapy for malignant astrocytomas in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Basement membrane invasion of glioma cells mediated by integrin receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Transforming growth factors beta(1) (TGF-beta(1)) and TGF-beta(2) promote glioma cell migration via Up-regulation of alpha(V)beta(3) integrin expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

TGF-beta in the central nervous system: potential roles in ischemic injury and neurodegenerative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Transforming growth factor-beta 3 is required for secondary palate fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Transforming growth factor-beta-mediated p15(INK4B) induction and growth inhibition in astrocytes is SMAD3-dependent and a pathway prominently altered in human glioma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Modulation of T-cell function by gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Latent transforming growth factor-beta binding proteins (LTBPs)--structural extracellular matrix proteins for targeting TGF-beta action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Models of T cell anergy: is there a common molecular mechanism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Decorin gene transfer-mediated suppression of TGF-beta synthesis abrogates experimental malignant glioma growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Detection of active form of transforming growth factor-beta in cerebrospinal fluid of patients with glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Effects of transforming growth factor beta 1 on astroglial cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Neural cell adhesion molecule L1 in gliomas: correlation with TGF-beta and p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

The role of integrins in the malignant phenotype of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Macrophage- and astrocyte-derived transforming growth factor beta as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Immunoregulatory role of transforming growth factor beta (TGF-beta) in development of killer cells: comparison of active and latent TGF-beta 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Transforming growth factor-beta 2 induces apoptosis of murine T cell clones without down-regulating bcl-2 mRNA expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Mechanism of activation of the TGF-beta receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Enhanced expression of transforming growth factor-beta and its type-I and type-II receptors in human glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Negative regulation of transforming growth factor-beta by the proteoglycan decorin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Transforming growth factor-beta 2 down-regulates HLA-DR antigen expression on human malignant glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C401%3A%3AAID-JEMT1025%3E3.0.CO%3B2-C

10.1002/1097-0029(20010215)52:4<401::AID-JEMT1025>3.0.CO;2-C

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11170299